This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
May 04, 2018
BONESUPPORT HOLDING AB (Publ) – Q1 Interim Report
May 03, 2018
Targovax ASA: First quarter 2018 results
May 02, 2018
Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma
May 02, 2018
Q1 2018 General Market Overview
April 27, 2018
Wilson Therapeutics’ 2017 Annual Report published
April 26, 2018
Strongbridge Biopharma plc to Host First Quarter 2018 Financial Results Conference Call on May 10, 2018
April 24, 2018
Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
April 24, 2018
Onxeo Announces Initiation of DRIIV Phase I Clinical Trial of AsiDNA™ for Treatment of Advanced Solid Tumor
April 23, 2018
MIPS receives a positive decision in European patent case
April 20, 2018
Nexstim Plc to present at BioTrinity 2018 in London